Vanguard Capital Management
NXTC icon

Vanguard Capital Management’s NextCure NXTC Stock Holding History

Vanguard Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
156,842
-3,631
-2% -$26.8K ﹤0.01% 3802
2026
Q1 		$1.69M Buy
+160,473
New +$1.96M ﹤0.01% 3416

Other funds holding NXTC

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
Verdad Advisers Boston, Massachusetts $104M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vanguard Capital Management's NXTC Position: Q2 2026 in Review

Vanguard Capital Management reduced its NextCure (NXTC) stake by 2.3% in Q2 2026, selling an estimated $26.8K and leaving 156,842 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Vanguard Capital Management first reported a position in NXTC in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.69M in Q1 2026. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Vanguard Capital Management held 156,842 shares of NextCure worth $251K as of Q2 2026.
  • Vanguard Capital Management sold 3,631 NextCure shares in Q2 2026, an estimated $26.8K.
  • NextCure made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3802 holding.
  • Vanguard Capital Management first reported a position in NextCure in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's NextCure position peaked at $1.69M in Q1 2026.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.